Culture Medium, Per Se Patents (Class 435/404)
-
Publication number: 20110171624Abstract: A medium solution which will increase the growth, survival and ultimately the live birth rate of oocytes and embryos which have been or will be subjected to cryopreservation. The solution contains varied amounts of glucose, pyruvates, amino acids, vitamins K5 and C, antioxidants, fatty acids to supply the specimens with the chemical ingredients and uptake requirements required to recover and prosper during and after the cryopreservation process. The solution supplies nutrients to the specimens that will replenish depletion and damage to the specimens and their mitochondria, spindles and structural features, such as cell walls. One formulation addresses the additional requirements of frozen specimens as opposed to the current media solutions and methods which treat the un-frozen specimens the same as the frozen specimens when recovering them from cryopreservation.Type: ApplicationFiled: March 25, 2011Publication date: July 14, 2011Inventor: Michael D. Cecchi
-
Publication number: 20110165128Abstract: The present invention relates to expression of CXCR4 in mesenchymal stem cells (MSCs) and homing of MSCs to sites of injury. In particular, the invention provides expanded cultures of MSCs which maintain cell surface expression of CXCR4. The MSCs are capable of homing to sites of injury and are suitable for treatment of ischemic disorders, including cardiac disorders, bone and cartilage disorders, liver disorders, inflammatory disorders, and stroke.Type: ApplicationFiled: March 6, 2009Publication date: July 7, 2011Applicant: Columbia University in the City of New YorkInventors: Sergey V. Doronin, Irina A. Potapova, Ira S. Cohen, Michael R. Rosen, Richard B. Robinson, Peter R. Brink
-
Publication number: 20110151512Abstract: The present invention relates to oligopeptide-free cell culture media comprising at least 0.5 mg/L of a polyamine and to methods for cultivating cells in said oligopeptide-free cell culture media comprising at least 0.5 mg/L of a polyamine. The invention also relates to methods for expressing at least one protein in a medium comprising at least 0.5 mg/L of a polyamine and to methods for producing at least one virus in a medium comprising at least 0.5 mg/L of a polyamine.Type: ApplicationFiled: February 25, 2011Publication date: June 23, 2011Applicants: Baxter International Inc., Baxter Healthcare S.A.Inventors: Leopold Grillberger, Manfred Reiter, Wolfgang Mundt, Artur Mitterer
-
Publication number: 20110151011Abstract: This invention provides a method for decellularizing adipose tissue, comprising subjecting the adipose tissue to one or more incubations in an enzymatic digestion solution containing one or more enzymes, and one or more solvent extractions, wherein decellularized adipose tissue comprising an extracellular matrix with well-preserved three-dimensional structure is obtained. The invention also provides a decellularized adipose tissue comprising an extracellular matrix with well-preserved three-dimensional architecture, and bioscaffolds, microcarrier beads, and coatings comprising the decellularized adipose tissue.Type: ApplicationFiled: December 17, 2010Publication date: June 23, 2011Inventor: Lauren E. Flynn
-
Publication number: 20110142809Abstract: The present invention relates to a method for separating highly active stem cells from human stem cells, the highly active stem cells separated by the method, a cell therapeutic agent containing the stem cells, and a medium for separating the highly active stem cells from stem cells containing a specific cytokine. According to the present invention, the method is useful for separating the highly efficient stem cells from mesenchymal stem cells of various origins. Further, the method is very useful in developing a cell therapeutic agent of high efficiency because the method can be applicable to stem cells of various origins which are cultured under different conditions. Senescent stem cells increased by several passage times in vitro can be effectively sorted out, so the method can be used for reactivating the stem cells.Type: ApplicationFiled: July 17, 2009Publication date: June 16, 2011Applicant: SEOUL NATIONAL UNIVERSITY HOSPITALInventors: Hyo Soo Kim, Eun-Ju Lee, Hyun-Jae Kang
-
Publication number: 20110143432Abstract: The invention relates to the use of extract of selenium-enriched yeast (Se-YE) as a supplement to the serum-free cell culture media formulations. The cell culture media comprising this supplement are particularly suitable for cultivating mammalian cells and for production of recombinant proteins and monoclonal antibodies.Type: ApplicationFiled: June 9, 2009Publication date: June 16, 2011Applicants: AS Vahiuuringute Tehnoloogia Arenduskekus, Celecure AS, Tallinn University of Technology, Pohja-Eesti Regionaalhaigla SA, Inbio OU, Kevelt AS, Cambrex Tallinn ASInventors: Monika Drews, Reet Rumvolt, Karoli Voodla
-
Publication number: 20110137012Abstract: Methods of culturing cells capable of producing desired proteins to obtain the proteins by use of a medium from which biological components are excluded as much as possible are provided. Specifically, a culture method characterized by culturing while maintaining a specific amino acid in a culture solution at a high concentration, and a cell culture fed-batch medium for use in the method are provided.Type: ApplicationFiled: April 25, 2008Publication date: June 9, 2011Inventors: Satoshi Katayama, Shouhei Kishishita, Kunihiko Kodaira, Makoto Sadamitsu, Yoshinori Takagi, Hiroki Matsuda
-
Publication number: 20110129439Abstract: The invention is in the field of regenerative medicine. It has been found that the conditioned medium of non-oval pluripotent liver progenitor cells exerts a tissue regenerating effect. A preparation of the cell free conditioned medium is therefore useful in the treatment of injury and organ failure, preferably liver and/or injury or failure.Type: ApplicationFiled: June 11, 2009Publication date: June 2, 2011Inventors: Maria Beatriz Herrera Sanchez, Valentina Fonsato, Tetta Ciro, Camussi Giovanni
-
Publication number: 20110129926Abstract: The present invention relates to nutritive medium, medium supplement, media subgroup and buffer formulations. The present invention provides powder nutritive medium, medium supplement and medium subgroup formulations, e.g., cell culture medium supplements (including powdered sera such as powdered fetal bovine serum (FBS)), medium subgroup formulations and cell culture media comprising all of the necessary nutritive factors that facilitate the in vitro cultivation of cells. The invention further provides powder buffer formulations that produce particular ionic and pH conditions upon reconstitution with a solvent. The invention provides methods for production of media, media supplement, media subgroup and buffer formulations, and also provides kits and methods for cultivation of prokaryotic and eukaryotic cells, particularly bacterial cells, yeast cells, plant cells and animal cells (including human cells) using these dry powder nutritive media, media supplement, media subgroup and buffer formulations.Type: ApplicationFiled: January 27, 2011Publication date: June 2, 2011Applicant: LIFE TECHNOLOGIES CORPORATIONInventors: Richard M. FIKE, William WHITFORD, Richard F. HASSETT, Jeffrey W. BIDDLE, Laurel BIDDLE, Christine M. BIDDLE, Robert C. RADOMINSKI, Barbara M. DADEY
-
Patent number: 7951593Abstract: The present invention relates to a gingival fibroblast culture medium free of animal serum, comprising an animal cell culture medium, free of animal serum, to which is added: from 0.1 ng/ml to 100 ng/ml bFGF, and/or from 1 ?g/ml to 50 ?g/ml insulin.Type: GrantFiled: March 19, 2008Date of Patent: May 31, 2011Assignee: Universite Rene Descartes-Paris VInventors: Bruno Gogly, Bernard Coulomb, Antoine Lafont
-
Patent number: 7951577Abstract: Liquid crystal compositions that exhibit little or no toxicity with respect to cells include liquid crystals with chemical functional groups such as fluorine atoms, fluorophenyl groups, or difluorophenyl groups. Liquid crystals with little or no toxicity to cell lines may be added to cell culture media or added to components used in cell culture media. Cells may be grown in cell culture media that includes liquid crystals that exhibit little or no toxicity to cells.Type: GrantFiled: October 23, 2007Date of Patent: May 31, 2011Assignee: Wisconsin Alumni Research FoundationInventors: Christopher John Murphy, Nicholas L. Abbott, Yan-Yeung Luk, Sean Francis Campbell, Li-Lin Cheng, Chang-Hyun Jang
-
Storage agent for preservation of an animal cell, tissue or organ, and preserved process of the same
Patent number: 7951590Abstract: The present invention relates to a storage agent for preservation of an animal cell, animal tissue or organ and a method of preserving an animal cell, animal tissue, animal blood or an organ. The storage agent has polyphenol as an effective ingredient. The storage agent stabilizes protein or is added to blood, corpuscles or platelets. Also, the storage agent prevents or treats an organ injury caused by a transplant operation.Type: GrantFiled: May 15, 2000Date of Patent: May 31, 2011Assignee: MG Pharmacy Ltd.Inventor: Shokyu Gen -
Publication number: 20110124025Abstract: A cell collecting device having a housing with an inlet for receiving cells, a cell attractant cavity have a cell attractant, a cell collection channel running from the inlet to the cell attractant cavity, and a plurality of electrodes positioned to detect the presence of cells is disclosed. The cell attractant cavity may include a porous medium, such as, a hydrogel, containing the cell attractant, such as, epidermal growth factor. The channel may include a plurality of restrictions and expansions to assist in maintaining the porous medium while permitting the passage of attractant and cells. The device may be implanted into a patient for an extended period of time, and then removed and examined. A method for collecting cells, an implantable attractant dispersing device, and a porous medium for controlled releasing of a compound are also disclosed.Type: ApplicationFiled: November 20, 2009Publication date: May 26, 2011Applicant: COLLEGE OF NANOSCALE SCIENCE AND ENGINEERINGInventors: James CASTRACANE, Waseem Khan RAJA
-
Publication number: 20110117651Abstract: The subject invention discloses an agent for promoting cell adhesion to a support, comprising a dispirotripiperazine derivative represented by Formula I below or a salt thereof; a method for promoting cell adhesion to a support comprising adding the dispirotripiperazine derivative represented by Formula I below or a salt thereof to a culture medium, or applying the same to a support; and an agonist of a heparin sulfate that comprises the dispirotripiperazine derivative represented by Formula I below or a salt thereof, and that promotes cell adhesion and/or cell growth.Type: ApplicationFiled: June 16, 2009Publication date: May 19, 2011Inventors: Motonari Uesugi, Sayumi Yamazoe
-
Publication number: 20110104804Abstract: A mixing device for mixing a first and second material together to create an output mixture. The device includes a first chamber containing the first material coupled to a mixing chamber defined between a rotor and a stator. The rotor is disposed inside the stator and rotates therein about an axis of rotation. The first chamber houses an internal pump configured to pump the first material from the first chamber into the mixing chamber. The pump may be configured to impart a circumferential velocity into the first material before it enters the mixing chamber. At least one of the rotor and stator have a plurality of through-holes through which the second material is provided to the mixing chamber. Optionally, a second chamber is coupled to the mixing chamber. The second chamber may house an internal pump configured to pump the output material from the mixing chamber into the second chamber.Type: ApplicationFiled: November 12, 2010Publication date: May 5, 2011Applicant: Revalesio CorporationInventors: Anthony B. Wood, Gregory J. Archambeau, Richard L. Watson
-
Publication number: 20110091936Abstract: The present invention relates generally to glutamine-free cell culture media supplemented with arginine. The invention further concerns the production of recombinant proteins, such as antibodies, in arginine-supplemented glutamine-free mammalian cell culture.Type: ApplicationFiled: August 6, 2010Publication date: April 21, 2011Inventors: Martin GAWLITZEK, Shun Luo, Christina Teresa Petraglia
-
Publication number: 20110086008Abstract: The present invention relates to a new method for repairing human or animal tissues such as cartilage, meniscus, ligament, tendon, bone, skin, cornea, periodontal tissues, abscesses, resected tumors, and ulcers. The method comprises the step of introducing into the tissue a temperature-dependent polymer gel composition such that the composition adhere to the tissue and promote support for cell proliferation for repairing the tissue. Other than a polymer, the composition preferably comprises a blood component such as whole blood, processed blood, venous blood, arterial blood, blood from bone, blood from bone-marrow, bone marrow, umbilical cord blood, placenta blood, erythrocytes, leukocytes, monocytes, platelets, fibrinogen, thrombin and platelet rich plasma. The present invention also relates to a new composition to be used with the method of the present invention.Type: ApplicationFiled: October 8, 2010Publication date: April 14, 2011Inventors: Caroline D. HOEMANN, Michael D. Buschmann, Marc D. Mckee
-
Publication number: 20110086377Abstract: A droplet actuator comprising: (a) a base substrate comprising electrodes configured for conducting droplet operations on a droplet operations surface thereof; (b) a droplet comprising one or more beads situated on the droplet operations surface; (c) a barrier arranged in relation to the droplet and the electrodes such that a droplet may be transported away from the beads using one or more droplet operations mediated by one or more of the electrodes while transport of the beads is restrained by a barrier. Related methods and kits are also provided.Type: ApplicationFiled: August 25, 2008Publication date: April 14, 2011Applicant: ADVANCED LIQUID LOGIC, INC.Inventors: Prasanna Thwar, Dwayne Allen, Philip Paik
-
Patent number: 7923245Abstract: The present invention discloses a medium for a serum-free medium capable of culturing ES cells for a long period while maintaining their undifferentiated state without using feeder cells, and a basal medium for producing the medium thus described. The basal medium of the present invention is characterized by that it has composition shown by Table I. Further, the present invention discloses a medium for ES cells produced with the basal medium.Type: GrantFiled: December 27, 2004Date of Patent: April 12, 2011Inventors: Miho Furue, Tetsuji Okamoto, Makoto Asashima
-
Publication number: 20110081722Abstract: The present invention relates to animal protein-free cell culture media comprising polyamines and a plant- and/or yeast-derived hydrolysate. The invention also relates to animal protein-free culturing processes, wherein cells can be cultivated, propagated and passaged without adding supplementary animal proteins in the culture medium. These processes are useful in cultivating cells, such as recombinant cells or cells infected with a virus, and for producing biological products by cell culture processes.Type: ApplicationFiled: May 17, 2010Publication date: April 7, 2011Applicants: Baxter International Inc., Baxter Healthcare S.A.Inventors: Leopold Grillberger, Manfred Reiter, Wolfgang Mundt, Friedrich Dorner
-
Publication number: 20110081325Abstract: Provided is a novel therapeutic approach for the treatment of heart failure and diseases associated therewith. In particular, vinca alkaloids are used for improving the viability of cardiomyocytes and preventing myocardial infarction.Type: ApplicationFiled: June 2, 2009Publication date: April 7, 2011Applicant: Axiogenesis AGInventor: Heribert Bohlen
-
Publication number: 20110082100Abstract: Compounds containing nucleic acid bases or their precursors modified by enrichment at specific sites with heavy stable isotopes of elements naturally present at those sites in minute amount are useful for the treatment of diseases characterized by altered gene expression and altered pattern of epigenomic control. These compounds, when used as nutrients or in other medicinal application methods, can alter the DNA methylation pattern in a simple way through the well-understood mechanism of kinetic isotope effect (KIE). This effect could also be useful for modifying methylation kinetics in stem cell technology, cloning and as disease therapeutics.Type: ApplicationFiled: March 13, 2009Publication date: April 7, 2011Inventor: Mikhail S. Shchepinov
-
MEDIUM FOR HANDLING AND STORING BIOLOGICAL TISSUES OF THE MUSCULOSKELETAL SYSTEM OUTSIDE AN ORGANISM
Publication number: 20110070204Abstract: The present disclosure relates to a medium for handling, including storing, cultivating, coating, impregnating and/or preserving musculoskeletal tissues such as bone, cartilage, tendon, muscle, nerve, ligament, blood vessel, skin, fascia, bursa and joint capsule tissue or cells, wherein the medium is an aqueous solution comprising hyaluronan and a first saccharide, polyol, or combination thereof. Further disclosed are methods of handling musculoskeletal tissue or cells or preserving the viability of these tissues or cells using this medium as well as the preserved tissues or cells.Type: ApplicationFiled: September 17, 2010Publication date: March 24, 2011Inventor: Ilan Elias -
Publication number: 20110070276Abstract: Compositions containing biologically active peptides are disclosed. Active peptides are isolated fragments derived from human hair or sheep wool keratin proteins. Compositions may be prepared for pharmaceutical or topical administration or for use in cosmetic preparations.Type: ApplicationFiled: February 26, 2009Publication date: March 24, 2011Inventor: Donald R. Cowsar
-
Publication number: 20110064701Abstract: The present invention relates to pluripotent stem cells, particularly to pluripotent embryonic-like stem cells. The invention further relates to methods of purifying pluripotent embryonic-like stem cells and to compositions, cultures and clones thereof. The present invention also relates to a method of transplanting the pluripotent stem cells of the present invention in a mammalian host, such as human, comprising introducing the stem cells, into the host. The invention further relates to methods of in vivo administration of a protein or gene of interest comprising transfecting a pluripotent stem cell with a construct comprising DNA which encodes a protein of interest and then introducing the stem cell into the host where the protein or gene of interest is expressed. The present also relates to methods of producing mesodermal, endodermal or ectodermal lineage-committed cells by culturing or transplantation of the pluripotent stem cells of the present invention.Type: ApplicationFiled: April 23, 2010Publication date: March 17, 2011Inventors: Henry E. Young, Paul A. Lucas
-
Patent number: 7906024Abstract: The addition of buffer to a harvest stream during diafiltration can cause increased turbidity and have other undesirable effects including limiting product recovery. Methods and compositions related to the use of a non-ionic surfactant are provided for improving diafiltration.Type: GrantFiled: January 24, 2006Date of Patent: March 15, 2011Assignee: Wyeth Research Ireland LimitedInventors: James Pierce, Enda Moran
-
Publication number: 20110052548Abstract: This invention provides compositions for differentiating an isolated embryonic stem cell or an isolated embryoid body into neuronal progenitor cells and methods for using same.Type: ApplicationFiled: August 26, 2010Publication date: March 3, 2011Inventors: Wei-Chun Chin, Eric Yi-Tong Chen, Tzu-I Chao, Chi-Shuo Chen
-
Publication number: 20110053266Abstract: The present invention relates to methods and kits for expanding a stem cell population. More particularly, the invention relates, inter alia, to methods, kits, and compositions for expanding a stem cell population, particularly a hematopoietic stem cell population.Type: ApplicationFiled: June 16, 2010Publication date: March 3, 2011Inventors: John M. Perry, Linheng Li, Justin C. Grindley
-
Publication number: 20110053271Abstract: A method for grafting a polysaccharide to a surface of a cell culture article includes (a) contacting the surface of the article with the polysaccharide in a dry form; and (b) exposing the surface of the article and contacted dry polysaccharide to ionizing radiation to graft the polysaccharide to the surface of the article. In addition to grafting the polysaccharide to the surface, the ionizing radiation may serve to sterilize the article.Type: ApplicationFiled: August 25, 2009Publication date: March 3, 2011Inventors: Odessa N. Petzold, Vasudha Ravichandran, Wageesha Senaratne
-
Publication number: 20110052529Abstract: The present invention provides methods and compositions for expanding Treg cells ex vivo or in vivo using one or more conjugates comprising a costimulatory moiety that stimulates at least one of three signals involved in Treg cell development and/or using dendritic cells pulsed with antigens and modified to display TGF-?, or hematopoetic stem cells or bone marrow cells modified to display TGF-?. The methods and compositions are useful, for example, in the treatment and prevention of autoimmune disease, including Type 1 diabetes and in preventing foreign graft rejection, as well as to establish mixed chimerism, induce tolerance to autoantigens, alloantigens or xenoantigens, beta cell regeneration, prevention of foreign graft rejection, and treatment of a genetically inherited hematopoietic disorder.Type: ApplicationFiled: June 25, 2010Publication date: March 3, 2011Inventor: Haval Shirwan
-
Patent number: 7897388Abstract: This invention is concerned with stem cells derived from umbilical cord blood serum and a method for growing human embryonic stem cells and adult cells comprising sera separated from clotted umbilical cord blood, including growing and differentiating cord blood stem cells into neural precursors, comprising transdifferentiating CD34+, CD45+ and CD133+ stem cells from mononuclear cells derived from umbilical cord blood to neural precursors. The stem cells obtained from the umbilical cord include pluripotent stem and progenitor cell population of mononuclear cells, and separating pluripotent stem and progenitor cell population of mononuclear cells obtained from the umbilical cord blood. A magnetic cell separator is used to separate out cells which contain a CD marker and then expanding the cells in a medium containing retinoic acid as a differentiating agent supplemented with one or more growth factors BDNF, GDNF, NGF and FGF in presence of cord blood serum.Type: GrantFiled: October 31, 2007Date of Patent: March 1, 2011Assignee: Reliance Life Sciences Pvt. Ltd.Inventors: Prathibha Shetty, Chandra Viswanathan
-
Patent number: 7892830Abstract: While culture medium and systems have been described that permit the culture and proliferation of human embryonic stem cells in feeder free and animal product free conditions, these conditions will not readily support cloning of an embryonic stem cell culture meaning, at least here, the initiation of a sub-culture using one or a very few originating cells. It has been found here that a class of small molecules that are inhibitors of kinase enzymes will increase the efficiency of cloning of stem cell cultures sufficiently to make such cloning practical in the defined medium and in other media as well.Type: GrantFiled: January 17, 2008Date of Patent: February 22, 2011Assignee: Wisconsin Alumni Research FoundationInventors: Veit Bergendahl, James A. Thomson
-
Publication number: 20110039333Abstract: The invention relates to human pluripotent cells. More specifically, the invention provides a chemically defined xeno-free culture system that allows for long term expansion of human pluripotent cells. This culture system allows for human pluripotent cell lines to be maintained in the pluripotent state for an extended time while maintaining a normal karyotype and the ability to differentiate into all three germ layers.Type: ApplicationFiled: August 12, 2010Publication date: February 17, 2011Applicant: UNIVERSITY OF SOUTHERN CALIFORNIAInventors: Michael Kahn, Kouichi Hasegawa, Jia-Ling Teo, Michael McMillan
-
Publication number: 20110031391Abstract: A method for identifying a biological analyte that is affected by a stressor is disclosed in which two substantially identical biological samples are provided, with a first sample being a control sample and a second sample being an experimental sample. The control sample is grown with a nutrient having an isotope of a first atom, whereas the experimental sample is grown with a nutrient having a second isotope of the first atom. The experimental sample is grown with a stressing agent and regimen. The samples are admixed, and the formed composite is mass spectroscopically assayed for analyte peaks. The ratio of first isotope to second isotope is determined for the peaks, as is a sample median isotopic ratio. The ratio for assayed analyte peaks is compared with the median ratio. An analyte whose isotopic ratio significantly deviates from the median ratio is an analyte affected by the stressing agent.Type: ApplicationFiled: October 25, 2010Publication date: February 10, 2011Inventor: Christopher William Ward Beecher
-
Publication number: 20110027348Abstract: Composition and method for preventing, treating or attenuating inflammatory diseases by way of inhibiting lipid peroxidation and subsequent elementary inflammation through ensuring the presence of the following biologically active ingredients in the PMRS of cells involved in inflammation: i) at least one killed probiotic and ii) at least one omega 3 FA and iii) vitamin E and iv) ubiquinone by introducing a composition comprising any of the missing ingredients.Type: ApplicationFiled: August 27, 2007Publication date: February 3, 2011Inventor: Janos FEHER
-
Publication number: 20110027890Abstract: A ligand construct containing at least two, identical or different, ligand molecules which are capable of binding to a cell surface receptor, the ligand molecules being coupled via a spacer, wherein the ligand construct has at least one functional group for binding substrates. According to the ligand construct of the present invention, the immobilization of the ligand construct to various artificial substrates is facilitated, so that an artificial matrix can be easily prepared on an optimal substrate, whereby cells can be stably cultured.Type: ApplicationFiled: December 25, 2006Publication date: February 3, 2011Applicant: KURARAY CO., LTD.Inventors: Akio Fujita, Yuji Hotta, Keiko Oka, Michiyo Takagi
-
Publication number: 20110027891Abstract: The present invention relates to mammalian cell culture media which comprise supernatant from some of the fractions of human plasma fractionation according to the Cohn method, more specifically, the supernatant of fractions I and II+III. When said supernatant is added as a culture medium supplement it provides various nutrients and factors for the effective maintenance and/or proliferation of the cultured mammalian cells. In addition, the present invention relates to the preparation process and use of said medium in the culture of mammalian cells.Type: ApplicationFiled: July 2, 2010Publication date: February 3, 2011Applicant: GRIFOLS, S.A.Inventors: Juan Ignacio JORQUERA NIETO, Montserrat Costa Rierola, José MarÃa Diez Cervantes
-
Publication number: 20110020930Abstract: Subjecting a heterogeneous cell population (one with both stem cells and non-stem cells) to extreme stress selectively eliminated the non-stem cells and resulted in the enrichment of stem cells in the population. The stress can take many forms, including without limitation, cell toxins, high temperature, high salt, and low oxygen (hypoxic) conditions. The number of stem cells remaining after stress were increased, and showed increased expression of traditional stem cell markers. The stem cells were shown to be capable of proliferation and differentiation into multiple types of cells. This method allows purification of stem cells from adult heterogeneous cell populations on a large scale basis without requirement of expensive equipment, and without requiring the presence of cell surface markers. Stem cells produced by the above method can be used for clinical applications, including tissue engineering.Type: ApplicationFiled: July 23, 2010Publication date: January 27, 2011Inventors: GARY E. WISE, SHAOMIAN YAO
-
Publication number: 20110008886Abstract: Compositions and methods for isolating and purifying islet cells are described. Islets obtained using such compositions and methods can be transplanted into diabetic patients.Type: ApplicationFiled: May 10, 2010Publication date: January 13, 2011Applicant: REGENTS OF THE UNIVERSITY OF MINNESOTAInventors: Bernhard J. Hering, Shinichi Matsumoto
-
Publication number: 20110008893Abstract: Disclosed are a medium for mammalian somatic cells with which mammalian somatic cells can be grown effectively when the mammalian somatic cells are cultured, while reducing the amount of serum to be added to the medium as much as possible or without adding serum thereto, and an additive to constitute the medium. By blending of a ligand for an endothelial cell differentiation gene (Edg) family receptor and a ligand for a serotonin receptor to a medium, somatic cells of mammals can be grown even in cases where the medium does not contain serum at all or contains only a small amount thereof.Type: ApplicationFiled: December 26, 2008Publication date: January 13, 2011Applicant: FUJIREBIO INC.Inventors: Itsuro Sugimura, Yoshiyuki Hotta, Harumi Yamaguma
-
Publication number: 20110002944Abstract: The instant invention provides methods and compositions for promoting neural cell growth by inhibiting myelin associated glycoprotein (MAG)-induced inhibition of axonal regeneration. The invention relates to methods for identifying agents that inhibit MAG-induced inhibition of neural cell growth. Methods for inhibiting myelin associated glycoprotein (MAG)-induced inhibition of neural cell growth in a patient, methods for treating or preventing a MAG-induced disease or disorder of the CNS or PNS, comprising the step of administering at least one of the compositions according to this invention are provided. The invention includes kits comprising one or more agents identified according to the invention.Type: ApplicationFiled: February 13, 2007Publication date: January 6, 2011Applicant: The Johns Hopkins UniversityInventors: Guo-li Ming, Eyleen Lay Keow Goh, Hongjun Song
-
Publication number: 20100330677Abstract: Expression of reprogramming factors such as Sox2, klf4, c-myc, Nanog, LIN28 and Oct4 followed by culture in a MEK inhibitor and a GSK3 inhibitor reprograms tissue cells. The invention provides new uses of these inhibitors, for example in inducing completion of the transcriptional resetting of so-called pre-pluripotent (pre-iPS) stem cells, for example as obtained from mammalian neural stem cells or epiblast stem cells treated with single or combinations of the reprogramming factors, expressed transiently or by integrative vectors. Also provided are systems for reprogramming an epiplast stem cells independently of the use of there inhibitors.Type: ApplicationFiled: February 11, 2009Publication date: December 30, 2010Applicant: Cambridge Enterprise LimitedInventor: Austin Gerard Smith
-
Publication number: 20100323401Abstract: This invention relates to an in vitro method of producing antigen specific B cells and antibodies that provides for the capture of an entire primary human antibody repertoire for any foreign antigen, allows for screening large numbers of immunogen/adjuvant combinations, and permits the isolation of human monoclonal antibodies on demand thereby obviating the need to immunize humans with the target antigen.Type: ApplicationFiled: May 11, 2007Publication date: December 23, 2010Inventors: George K. Lewis, Yongjun Guan
-
Publication number: 20100323907Abstract: The invention is directed to a new composition for making a housing block for cryosectioning comprising agarose and optimal cutting temperature medium. The invention is further directed to new methods for making a frozen section microarray of fresh non-fixed frozen cell or tissue samples that undergo only one freeze-thaw cycle before being used in a biological assay.Type: ApplicationFiled: October 27, 2006Publication date: December 23, 2010Inventors: Long Ai Ton-That, Gavreel Kalantarov, Ilya Trakht
-
Publication number: 20100323027Abstract: We disclose a method of preparing a conditioned cell culture medium, the method comprising the steps of: (a) culturing a mesenchymal stem cell (MSC), a descendent thereof or a cell line derived therefrom in a cell culture medium; and (b) optionally isolating the cell culture medium; in which the mesenchymal stem cell (MSC) is obtained by propagating a cell obtained by dispersing a embryonic stem (ES) cell colony, or a descendent thereof, in the absence of co-culture in a serum free medium comprising FGF2.Type: ApplicationFiled: August 15, 2007Publication date: December 23, 2010Applicant: AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCHInventors: Sai Kiang Lim, Elias Lye
-
Patent number: 7855075Abstract: A method of ex-vivo expanding a population of stem cells, while at the same time inhibiting differentiation of the stem cells.Type: GrantFiled: May 19, 2008Date of Patent: December 21, 2010Assignees: Gamida Cell Ltd., Hadasit Medical Research Services and Development Ltd.Inventors: Tony Peled, Eitan Fibach, Avi Treves
-
Publication number: 20100316664Abstract: An agent for growing fibroblasts contains a yeast extract and a safflower extract as effective constituents. A method of growing fibroblasts comprises using a yeast extract and a safflower extract. An anti-aging agent for skin contains a yeast extract and a safflower extract as effective constituents.Type: ApplicationFiled: March 30, 2009Publication date: December 16, 2010Applicant: SHISEIDO COMPANY, LTD.Inventors: Masato Iino, Satoshi Amano
-
Publication number: 20100319078Abstract: A mammalian cell comprising a recombinant, functional L-threonine 3-dehydrogenase (EC 1.1.1.103; TDH) gene, methods of making, and methods of use.Type: ApplicationFiled: June 12, 2009Publication date: December 16, 2010Inventors: Steven L. McKnight, Jian Wang
-
Publication number: 20100310544Abstract: The invention is based on the finding that calcium ions and proteolytic enzymes, particularly papain, act in a synergetic way in the regeneration of skin and connective tissues. Thus, such a combination of active principles can be used for the preparation of culture media for cutaneous and/or connective tissue biopsies, which allow for the maintenance of the biopsies under viable conditions for periods of over 6 months, even for over 3 years, as well as for the preparation of pharmaceutical compositions or medical devices for the treatment of diseases in which the regeneration of cutaneous and connective tissues is beneficial (for instance, injuries and wounds, keloids, paradontopathies, conjunctivitis, nasal and ear polyps, cellulite, human and animal dermatitis), and for the preparation of cosmetic compositions that in particular have an anti-ageing effect on the skin.Type: ApplicationFiled: October 27, 2008Publication date: December 9, 2010Applicant: MEDEVICE S.P.A.Inventors: Luisa Gennero, Chiara Cesano, Carlo Vercelli, Antonio Ponzetto, Gianfranco Merizzi
-
Publication number: 20100310529Abstract: Isolated extracellular matrix from marrow adherent stromal cells and their descendents, which stimulates the growth and survival of a number of different neural cell types, is provided, along with methods for preparation and uses.Type: ApplicationFiled: December 3, 2008Publication date: December 9, 2010Inventor: Irina Aizman